{"version":"1.0","provider_name":"IRLAB","provider_url":"https:\/\/irlab.se\/sv\/","title":"VD kommentar Q1 2022 - IRLAB","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"9sXhbBXqHL\"><a href=\"https:\/\/irlab.se\/sv\/vd-kommentar-q1-2022\/\">VD kommentar Q1 2022<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/irlab.se\/sv\/vd-kommentar-q1-2022\/embed\/#?secret=9sXhbBXqHL\" width=\"600\" height=\"338\" title=\"\u201dVD kommentar Q1 2022\u201d &ndash; IRLAB\" data-secret=\"9sXhbBXqHL\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/irlab.se\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","description":"F\u00f6rsta kvartalet har passerat med flera nya milstolpar f\u00f6r IRLAB. En ny l\u00e4kemedelskandidat, IRL757, har presenterats och vi hyser stora f\u00f6rhoppningar om att den kan \u00f6ka livskvaliteten f\u00f6r alla de m\u00e4nniskor som idag har apati, ett mycket outh\u00e4rdligt symtom vid m\u00e5nga neurologiska sjukdomar som t ex Alzheimer och Parkinson. Den st\u00e4rkta kassapositionen efter mesdopetam-aff\u00e4ren och [&hellip;]"}